Home APPROVALS

APPROVALS

Regeneron’s antibody cocktail granted Emergency Use Authorisation
APPROVALS

Regeneron’s antibody cocktail granted Emergency Use Authorisation

Dominic Cuthbert -
0
RedHill’s second COVID candidate cleared in US for phase 2/3 study
APPROVALS

RedHill’s second COVID candidate cleared in US for phase 2/3 study

Dominic Cuthbert -
0
European approval for Tecentriq-Avastin combo for HCC
APPROVALS

European approval for Tecentriq-Avastin combo for HCC

Dominic Cuthbert -
0
FDA grants approval to broaden indication for Totect®
APPROVALS

FDA grants approval to broaden indication for Totect®

Tess Egginton -
0
Orphan designation for Novartis’ branaplam in Huntington’s disease
APPROVALS

Orphan designation for Novartis’ branaplam in Huntington’s disease

Dominic Cuthbert -
0
Forxiga recommended for approval in the EU for heart failure
APPROVALS

Forxiga recommended for approval in the EU for heart failure

Dominic Cuthbert -
0
Regeneron’s antibody cleared to treat Ebola in US
APPROVALS

Regeneron’s antibody cleared to treat Ebola in US

Dominic Cuthbert -
0
FDA clears ImmunityBio to trial novel COVID-19 vaccine candidate
APPROVALS

FDA clears ImmunityBio to trial novel COVID-19 vaccine candidate

Dominic Cuthbert -
0
CHMP recommends ViiV’s long-acting regimen for HIV
APPROVALS

CHMP recommends ViiV’s long-acting regimen for HIV

Dominic Cuthbert -
0
Nucala approved as first and only biologic treatment for Hypereosinophilic Syndrome
APPROVALS

Nucala approved as first and only biologic treatment for Hypereosinophilic Syndrome

Dominic Cuthbert -
0
123...73Page 1 of 73

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks